SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-18-009260
Filing Date
2018-06-27
Accepted
2018-06-27 09:29:06
Documents
9
Period of Report
2018-06-27

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 42478
2 ex1-1.htm EX-1.1 237589
3 ex4-1.htm EX-4.1 121247
4 ex5-1.htm EX-5.1 18420
5 ex5-2.htm EX-5.2 9130
6 ex99-1.htm EX-99.1 12257
7 ex5-1_001.jpg GRAPHIC 8073
8 ex5-1_002.jpg GRAPHIC 8624
9 image_001.jpg GRAPHIC 2822
  Complete submission text file 0001493152-18-009260.txt   469314
Mailing Address HASATAT 8 ST. MODI'IN, L3 7178106
Business Address HASATAT 8 ST. MODI'IN, L3 7178106 972-3-6346450
Vascular Biogenics Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36581 | Film No.: 18920660
SIC: 2834 Pharmaceutical Preparations